Takeda-partnered genomics startup hires first CEO

Seven months after launching with $70 million and a partnership with Takeda, genomics startup Ensoma Therapeutics has hired its first CEO in former BlueRock Therapeutics executive Emile Nuwaysir.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.